Page 41 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk
P. 41

PREDICTION OF FUTURE RHEUMATOID ARTHRITIS
 101.Ray P, Black S, Shinefield H, et al. Risk of rheumatoid arthritis following vaccination with 2 tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age. Vaccine 2011;29(38):6592–7.
102.Blaschke S, Schwarz G, Moneke D, et al. Epstein-Barr virus infection in peripheral blood mononuclear cells, synovial fluid cells, and synovial membranes of patients with rheu- matoid arthritis. J Rheumatol 2000;27(4):866–73.
103.Buskila D, Shnaider A, Neumann L, et al. Musculoskeletal manifestations and autoan- tibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998;28(2):107–13.
104.Sawada T, Hirohata S, Inoue T, et al. Development of rheumatoid arthritis after hepatitis C virus infection. Arthritis Rheum 1991;34(12):1620–1.
105.Medina-Rodriguez F, Guzman C, Jara LJ, et al. Rheumatic manifestations in human immu- nodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors. J Rheumatol 1993;20(11):1880–4.
106.Saebo A, Lassen J. Yersinia enterocolitica: an inducer of chronic inflammation. Int J Tissue React 1994;16(2):51–7.
107.Schaeverbeke T, Vernhes JP, Lequen L, et al. Mycoplasmas and arthritides. Rev Rhum Engl Ed 1997;64(2):120–8.
108.Hitchon CA, Chandad F, Ferucci ED, et al. Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol 2010;37(6):1105–12.
109.Mikuls TR, Thiele GM, Deane KD, et al. Porphyromonas gingivalis and diseaserelated autoantibodies in individuals at increased risk of rheumatoid arthritis. Arthritis Rheum 2012;64(11):3522–30.
110.Bengtsson C, Kapetanovic MC, Kallberg H, et al. Common vaccinations among adults do not increase the risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis 2010;69(10):1831–3.
111.Cohen AD, Shoenfeld Y. Vaccine-induced autoimmunity. J Autoimmun 1996; 9(6):699– 703.
112.Schattner A. Consequence or coincidence? The occurrence, pathogenesis and signifi- cance of autoimmune manifestations after viral vaccines. Vaccine 2005; 23(30):3876–86. 113.Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-‘vaccinosis’: a dangerous liai-
son? J Autoimmun 2000;14(1):1–10.
114.Symmons DP, Chakravarty K. Can immunisation trigger rheumatoid arthritis? Ann Rheum
Dis 1993;52(12):843–4.
115.Boyer JF, Gourraud PA, Cantagrel A, et al. Traditional cardiovascular risk factors in rheu-
matoid arthritis: a meta-analysis. Joint Bone Spine 2011;78(2):179–83.
116.Reynisdottir G, Karimi R, Joshua V, et al. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibodypositive rheumatoid
arthritis. Arthritis Rheumatol 2014;66(1):31–9.
117.Verstappen SM, Lunt M, Luben RN, et al. Demographic and disease-related predictors
of abnormal lung function in patients with established inflammatory polyarthritis and a comparison with the general population. Ann Rheum Dis 2013;72(9):1517–23.
39












































































   39   40   41   42   43